
Marico has entered into definitive agreements to acquire a 75% stake in Vietnam-based Skinetiq Joint Stock Company through its wholly owned subsidiary, Marico South-East Asia Corporation. The deal values Skinetiq at around ₹350 crore and will be completed through an all-cash transaction.
The acquisition will be carried out in 2 tranches, as per the exchange filing. Marico will pay about ₹222.3 crore on receipt of the 75% shareholding, followed by a 2nd payment of ₹39.3 crore, subject to certain conditions under the agreements.
The transaction is expected to close within 90 days of signing the agreements, subject to regulatory approvals and customary closing conditions.
Approval from Vietnam’s Department of Finance will be required before completion. The acquisition does not fall under related-party transactions, and the promoter group has no interest in the target company.
Following completion, Skinetiq will become a subsidiary of Marico’s South-East Asia arm. The subsidiary also holds the right to acquire the remaining shares after FY28, subject to milestone-based conditions.
Vietnam’s beauty market has seen a shift towards online channels, with roughly 50% of category consumption now coming from e-commerce and social commerce platforms.
Skinetiq operates with a mid-twenties EBITDA margin profile and focuses on active-ingredient skincare products, including retinol treatments, hydration masks and peptide-based formulations.
Skinetiq was founded in 2020 and operates in the beauty and personal care segment in Vietnam. The company owns the digital-first skincare brand Candid and holds exclusive distribution rights for the clinical skincare brand Murad in the country.
Its sales are largely driven by online and social commerce channels. The business reported revenue of about ₹152 crore in calendar year 2025, compared with ₹61 crore in 2024 and ₹45 crore in 2023.
Read More: Marico Share Price in Focus; To Invest ₹225.67 Crore for 60% Stake in Cosmix!
As of February 10, 2026, 10:55 am, Marico Ltd share price was trading at ₹756.60, a 0.23% increase from the previous closing price.
The investment gives Marico majority ownership in a Vietnam-based direct-to-consumer skincare business, with completion dependent on regulatory approvals and closing conditions.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Feb 10, 2026, 11:36 AM IST

Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
